Details of the Drug
General Information of Drug (ID: DMJDQGR)
Drug Name |
N,N-dimethyl-2,2-diphenylethanamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
UNII-MXF0417QII; MXF0417QII; AC1L35TO; CHEMBL10602; diphenylalkylamine (DPA), 4c; BDBM35931; ZINC1249433; 2-Dimethylamino-1,1-diphenylethane; 2-Dimethylamino-1,1-diphenyl-aethan; N,N-Dimethyl-2,2-diphenylethylamine; STL298137; AKOS022110055; MCULE-9768764141; NCGC00246407-01; Ethylamine, N,N-dimethyl-2,2-diphenyl-; Benzeneethanamine, N,N-dimethyl-beta-phenyl-; 2,2-diphenylethyl(dimethyl)amine; 2-Dimethylamino-1,1-diphenyl-aethan [WHO-DD]
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 225.33 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||